| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 6mg × 10 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 6mg × 20 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | - | お買物かごに入れる |
| 6mg × 30 tablet | ¥ 9281.94 錠剤 ¥ 309.40 | ¥ 309.40 | - | お買物かごに入れる |
| 6mg × 60 tablet | ¥ 11604.37 錠剤 ¥ 193.41 | ¥ 193.41 | - | お買物かごに入れる |
| 6mg × 90 tablet | ¥ 13926.79 錠剤 ¥ 154.74 | ¥ 154.74 | - | お買物かごに入れる |
| 6mg × 120 tablet | ¥ 15475.07 錠剤 ¥ 128.96 | ¥ 128.96 | - | お買物かごに入れる |
| 6mg × 180 tablet | ¥ 20119.91 錠剤 ¥ 111.78 | ¥ 111.78 | - | お買物かごに入れる |
| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 24mg × 12 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 24mg × 24 tablet | ¥ 20119.91 錠剤 ¥ 838.33 | ¥ 838.33 | - | お買物かごに入れる |
| 24mg × 36 tablet 無料航空便配送 | ¥ 29409.60 錠剤 ¥ 816.93 | ¥ 816.93 | - | お買物かごに入れる |
| 24mg × 60 tablet 無料航空便配送 | ¥ 46440.69 錠剤 ¥ 774.01 | ¥ 774.01 | - | お買物かごに入れる |
| 24mg × 90 tablet 無料航空便配送 | ¥ 67342.48 錠剤 ¥ 748.25 | ¥ 748.25 | - | お買物かごに入れる |
| 24mg × 120 tablet 無料航空便配送 | ¥ 85147.71 錠剤 ¥ 709.56 | ¥ 709.56 | - | お買物かごに入れる |
| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 30mg × 12 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 30mg × 24 tablet 無料航空便配送 | ¥ 24764.75 錠剤 ¥ 1031.86 | ¥ 1031.86 | - | お買物かごに入れる |
| 30mg × 36 tablet 無料航空便配送 | ¥ 35602.72 錠剤 ¥ 988.96 | ¥ 988.96 | - | お買物かごに入れる |
| 30mg × 60 tablet 無料航空便配送 | ¥ 55730.37 錠剤 ¥ 928.84 | ¥ 928.84 | - | お買物かごに入れる |
| 30mg × 90 tablet 無料航空便配送 | ¥ 77406.31 錠剤 ¥ 860.07 | ¥ 860.07 | - | お買物かごに入れる |
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.